Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

KRX/950210 stock hub

KRX/950210 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

KRX/950210is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

96.2B

Korea Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

KRX/950210

In the news

Latest news · KRX/950210

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 9.8P50 17.1P75 31.9

Trailing P/E35.2

P25 12P50 23.1P75 39.5

ROE-0.9

P25 -17.1P50 0.7P75 8.5

ROIC-14.9

P25 -9P50 1.3P75 6.8

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All KRX/950210 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

174

Groups with data

Currency

KRW

Showing 174 of 174 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Singapore
Country code	KR
Employees	54
Enterprise value	KRW 185.2B
Exchange	Korea Stock Exchange
Financial currency	KRW
First seen	2026-05-10
Industry	Biotechnology
Isin	KR8702070002
Last refreshed	2026-05-10
Market cap	KRW 96.2B
Price	KRW 8,000
Price currency	KRW
Sector	Healthcare
Sic	2836
Symbol	krx/950210
Website	https://www.prestigebiopharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	14.22%
EV Earnings	13.54x
EV/FCF	-2.78x
EV/Sales	9.73x
FCF yield	-69.35%
P/B ratio	0.2x
P/E ratio	35.18x
P/S ratio	5.05x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBITDA Margin	-254.73%
Gross margin	-25.7%
Gross Profit	KRW -4.9B
Net Income	KRW 13.7B
Net Income Growth Years	1%
Pretax Margin	-23.81%
Profit Margin	71.89%
Profitable Years	1
ROA	-6.42
Roa5y	-5.57
ROCE	-13.32
ROE	-0.86
Roe5y	-10.86
ROIC	-14.94

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-41.8%
Cagr3y	-5.5%
Cagr5y	-23.33%
EPS Growth Years	1
Revenue Growth	224.15x
Revenue Growth Q	147.35x
Revenue Growth Quarters	6x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	KRW 0.03
Assets	KRW 665.8B
Cash	KRW 85B
Current Assets	KRW 120.9B
Current Liabilities	KRW 117.7B
Debt	KRW 88.6B
Debt Equity	KRW 0.18
Debt FCF	KRW -1.33
Equity	KRW 482.6B
Interest Coverage	-9.58
Liabilities	KRW 183.3B
Long Term Assets	KRW 544.9B
Long Term Liabilities	KRW 65.5B
Net Cash	KRW -3.7B
Net Cash By Market Cap	KRW -3.8
Net Debt Equity	KRW 0.01
Tangible Book Value	KRW 354.5B
Tangible Book Value Per Share	KRW 5,934
WACC	7.03

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.03
Inventory Turnover	0.98
Net Working Capital	KRW -20.8B
Quick ratio	0.74
Working Capital	KRW 3.2B
Working Capital Turnover	KRW 0.43

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.25%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-41.78%
200-day SMA	12,332.7
3Y total return	-15.61%
50-day SMA	9,570.6
50-day SMA vs 200-day SMA	50under200
5Y total return	-73.51%
All Time High	54,000
All Time High Change	-85.19%
All Time High Date	2021-02-15
All Time Low	7,020
All Time Low Change	13.96%
All Time Low Date	2023-01-03
ATR	393.9
Beta	0.54
Beta1y	0.04
Beta2y	-0.09
Ch YTD	-37.74
High	8,200
High52	20,000
High52 Date	2025-07-11
High52ch	-60%
Low	7,940
Low52	7,940
Low52 Date	2026-05-08
Low52ch	0.76%
Ma50ch	-16.41%
Price vs 200-day SMA	-35.13%
RSI	26.17
RSI Monthly	33.56
RSI Weekly	31.74
Sharpe ratio	-0.88x
Sortino ratio	-1.36
Total Return	-0.25%
Tr YTD	-37.74
Tr1m	-14.16%
Tr1w	-6.98%
Tr3m	-31.33%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	KRW -73B
Operating margin	-383.9

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,585,638%
Net Borrowing	-67,067,812,000
Shares Insiders	30.4%
Shares Institutions	0.11%
Shares Out	12,019,231
Shares Qo Q	-0.69%
Shares Yo Y	0.25%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	KRW -67.1B
Average Volume	95,283.55x
Bv Per Share	6,649
CAPEX	KRW -34.9B
Ch1m	-14.16
Ch1w	-6.98
Ch1y	-41.78
Ch3m	-31.33
Ch3y	-15.61
Ch5y	-73.51
Ch6m	-32.89
Change	-0.12%
Change From Open	-0.12
Close	8,010
Days Gap	0
Depreciation Amortization	24,567,408,500
Dollar Volume	742,600,000
Earnings Date	2026-05-29
EBIT	KRW -73B
EBITDA	KRW -48.5B
EPS	KRW 227
F Score	4
FCF	KRW -66.7B
FCF EV Yield	-36.01x
FCF Per Share	KRW -5,548
Financing CF	-64,837,859,000
Fiscal Year End	June
Founded	2,015
Goodwill	11,139,469,000
Graham Number	32060.73201
Graham Upside	300.8
Income Tax	KRW -318.6M
Investing CF	9,184,373,000
Is Primary Listing	1
Last Earnings Date	2026-02-27
Last Report Date	2025-12-31
Ma150	11,533.5
Ma150ch	-30.64%
Ma20	9,046
Ma20ch	-11.56%
Net CF	-81,824,504,000
Next Earnings Date	2026-05-29
Open	8,010
Position In Range	23.08
Ppne	340,129,340,000
Price Date	2026-05-08
Ptbv Ratio	0.27
Relative Volume	0.97x
Revenue	19,023,098,000x
SBC By Revenue	2.47x
Share Based Comp	470,113,000
Tax By Revenue	-1.67x
Tr6m	-32.89%
Volume	92,825
Z Score	-0.43

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does KRX/950210 pay a dividend?

Capital-return profile for this ticker.

Performance

KRX/950210 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns KRX/950210?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.1%

Share of float held by funds and institutions

Insider ownership

+30.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.2%

Negative means the company is buying back shares.

Technical

KRX/950210 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

26.2

Below 30: short-term oversold

Price vs 200-day MA

-35.1%

50/200-day relationship not available

Beta (5Y)

0.54

Less volatile than the market

Sharpe ratio

-0.88

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About KRX/950210

Hub-level FAQ points readers to the deeper analysis pages.

What is the current krx/950210 stock rating?

krx/950210 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full krx/950210 analysis?

The full report lives at /stocks/krx/950210/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for krx/950210?

The latest report frames krx/950210 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the krx/950210 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.